Islamophobia creating divisions, hijab becoming a 'weapon': Pak PM Imran at UNGA

Agencies
September 28, 2019

New York, Sept 28: Islamophobia has grown at an alarming pace after the 9/11 attacks and is creating divisions, with wearing of hijab becoming a "weapon" against the community in some countries, Pakistan Prime Minister Imran Khan said here on Friday.

Khan, who is currently on a week-long visit to the US, delivered his maiden address to the United Nations General Assembly and touched upon several issues, including climate change, money laundering and Islamophobia.

Khan said billions of Muslims were living as minorities in the western countries and since 9/11 attacks Islamophobia had grown at an "alarming" pace.

"Islamophobia is creating divisions, hijab is becoming a weapon; a woman can take off clothes but she can't put on more clothes. It started after 9/11 and it started because certain western leaders equated Islam with terrorism," he said.

Khan questioned the use of the term 'radical Islamic terrorism', saying there is only one Islam.

"There is no such thing as radical Islam," he said, pointing out that all religions have individuals carrying out radical acts.

"The basis of all religions is compassion and justice which differentiates us from the animal kingdom," he said.

The prime minister told the UN that there should be an understanding for other faiths, but they are seen as creating division among global population.

Khan said the radical Islamic terrorism used by leaders has caused Islamophobia and pain for Muslims.

"What message does this (the term) send? How is a person in New York going to distinguish between moderate Muslims and radical Muslims?" he asked.

"In European countries it is marginalising Muslims, and this leads to radicalisation. Some of the terrorists were from marginalised Muslim communities. We Muslim leaders have not addressed this issue. The Muslim leaders all became moderates and our government coined a phrase 'enlightened moderation'," he said.

Khan's remarks came a day after he announced that Pakistan, Turkey and Malaysia have decided to jointly launch an English language Islamic television channel to correct misperceptions and confront the challenges posed by Islamophobia.

"President Erdogan, PM Mahatir and myself had a meeting today in which we decided our 3 countries would jointly start an English language channel dedicated to confronting the challenges posed by Islamophobia and setting the record straight on our great religion - Islam," Khan said in a tweet.

"Misperceptions which bring people together against Muslims would be corrected; issue of blasphemy would be properly contextualized; series and films would be produced on Muslim history to educate/inform our own people and the world; Muslims would be given a dedicated media presence," he said.

Speaking about the climate change, Khan said so many leaders talked about the issue, but there was a lack of seriousness.

"We don't realise the urgency of the situation. We have so many ideas but ideas without funding are mere hallucinations," he said.

"Our country is one of the top 10 countries that are most affected by the climate change. Eighty per cent of our water comes from the glaciers. These glaciers are melting at a rapid pace. The glaciers are also in India in the Himalayas, Karakorum and the Hindu Kush.If nothing is done, I fear the people are going to be facing a huge catastrophe," he said. Khan said his government planted one billion trees in Khyber Pakhtunkhwa when it came to power and plans to plant 10 billion to counter global warming effects. "One country cannot do anything, it has to be a combined effort of the world, he said, urging the UN to push countries which contribute to green house gas emissions.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 8,2020

New Delhi, June 8: Only 20.26 lakh migrant workers of the targeted 8 crore such labourers have received free food grains in May and June (2020), according to data released by the Ministry of Consumer Affairs, Food and Public Distribution.

In the middle of May, as part of the Rs 20 lakh crore Atma Nirbhar Bharat package, the Modi government had announced that migrant labourers who are not covered under the National Food Security Act (NFSA) or any state-run PDS scheme, will receive free food grains for two months.

"Non-card holders shall be given 5 kg wheat or rice per person and 1 kg chana per family per month for the next 2 months. About 8 crore migrants will benefit from this scheme that will cost the government Rs 3500 crore,” Finance Minister Nirmala Sitharaman had said at a press conference following PM Modi’s announcement.

But the Ministry of Consumer Affairs, Food and Public Distribution said on Sunday, "The states and UTs have lifted 4.42 LMT (lakh metric tonne) of food grains and distributed 10,131 MT of it to 20.26 lakh beneficiaries."

It added, "The Government of India also approved 39,000 MT pulses for 1.96 crore migrant families. Around 28,306 MT gram/dal have been dispatched to the states and UTs. A total 15,413 MT gram have been lifted by various states and UTs". The state governments, the ministry added, had distributed only 631MT (metric tonnes) of gram so far.

Because of the constant movement of migrant workers, the Centre had said that the states will be responsible for identifying the migrants and subsequent food distribution.

The Centre claims it is spending approximately Rs 3,109 crore for food grains and Rs 280 crores for grams/chana under this package.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.